OPGN logo

OpGen (OPGN) EBITDA

Annual EBITDA

-$29.51 M
+$2.87 M+8.87%

December 31, 2023

Summary

Performance

1-Year Change

+8.87%

3-Year Change

-45.06%

5-Year Change

-137.11%

15-Year Change

-104.52%

OPGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.8%
OPGN annual EBITDA is higher than 43.8% of companies in Healthcare sector

High & Low

All-time High

-$4.99 M

3-Year Low

-$32.38 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OPGN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Jul 8, 2025
OPGN next annual earnings announcement is scheduled for Jul 8, 2025

OtherOPGNprofitabilitymetrics:

Annual Revenue

$3.42 M
OPGN annual revenue is $3.42 million

Annual Net Income

-$32.67 M
OPGN annual net profit is -$32.67 million

Annual EBIT

-$30.83 M
OPGN annual earnings before interest & taxes is -$30.83 million

Annual EPS

-$41.47
OPGN annual earnings per share is -$41.47

Quarterly EBITDA

$8.98 M
+$10.51 M+685.96%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+193.9%

5-Year Change

+380.83%

OPGN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.53%
OPGN quarterly EBITDA is higher than 82.53% of companies in Healthcare sector

High & Low

All-time High

$8.98 M
OPGN quarterly EBITDA is currently at an all-time high

3-Year Low

-$16.65 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OPGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Jul 8, 2025
OPGN next earnings announcement is scheduled for Jul 8, 2025

OtherOPGNprofitabilitymetrics:

Quarterly Revenue

-
OPGN quarterly revenue value is unknown

Quarterly Net Income

$8.93 M
OPGN quarterly net profit is $8.93 million

Quarterly EBIT

$8.93 M
OPGN quarterly earnings before interest & taxes is $8.93 million

Quarterly EPS

$1.35
OPGN quarterly earnings per share is $1.35

TTM EBITDA

-$8.88 M
+$12.30 M+58.07%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+72.59%

5-Year Change

+72.59%

OPGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.94%
OPGN TTM EBITDA is higher than 63.94% of companies in Healthcare sector

High & Low

All-time High

-$1.03 M

3-Year Low

-$32.38 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OPGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Jul 8, 2025
OPGN next earnings announcement is scheduled for Jul 8, 2025

OtherOPGNprofitabilitymetrics:

TTM Revenue

-
OPGN TTM revenue value is unknown

TTM Net Income

-$9.40 M
OPGN TTM net profit is -$9.40 million

TTM EBIT

-$9.25 M
OPGN TTM earnings before interest & taxes is -$9.25 million

TTM EPS

-$17.35
OPGN TTM earnings per share is -$17.35

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$29.51 M
OPGN annual EBITDA is -$29.51 million

Annual Net Income

-$32.67 M
OPGN annual net profit is -$32.67 million

Annual Interest Expense

$1.84 M
OPGN annual interest expense is $1.84 million

Annual Income Tax

$0.00
OPGN annual income tax is $0.00

Annual D&A

$1.32 M
OPGN annual depreciation & amortization is $1.32 million

OPGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.9%0.0%0.0%
3 y3 years-45.1%+193.9%+72.6%
5 y5 years-137.1%+380.8%+72.6%

OPGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.3%+8.9%at high+153.9%at high+72.6%
5 y5-year-160.3%+8.9%at high+153.9%at high+72.6%
alltimeall time-491.9%+8.9%at high+153.9%-761.4%+72.6%

OpGen EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$8.98 M(-686.0%)
-$8.88 M(-58.1%)
Jun 2024
-
-$1.53 M(-564.1%)
-$21.17 M(-13.3%)
Mar 2024
-
$330.20 K(-102.0%)
-$24.41 M(-17.3%)
Dec 2023
-$29.51 M(-8.9%)
-$16.65 M(+402.0%)
-$29.51 M(+31.6%)
Sep 2023
-
-$3.32 M(-30.5%)
-$22.42 M(-30.6%)
Jun 2023
-
-$4.77 M(+0.1%)
-$32.31 M(+0.5%)
Mar 2023
-
-$4.77 M(-50.1%)
-$32.13 M(-0.8%)
Dec 2022
-$32.38 M(+18.8%)
-$9.56 M(-27.6%)
-$32.38 M(+16.6%)
Sep 2022
-
-$13.21 M(+187.3%)
-$27.77 M(+49.5%)
Jun 2022
-
-$4.60 M(-8.4%)
-$18.58 M(-2.9%)
Mar 2022
-
-$5.02 M(+1.5%)
-$19.13 M(-29.8%)
Dec 2021
-$27.25 M(+33.9%)
-$4.95 M(+23.2%)
-$27.25 M(-0.7%)
Sep 2021
-
-$4.02 M(-21.9%)
-$27.43 M(-6.0%)
Jun 2021
-
-$5.15 M(-60.8%)
-$29.20 M(-2.0%)
Mar 2021
-
-$13.14 M(+155.9%)
-$29.79 M(+46.5%)
Dec 2020
-$20.34 M(+79.4%)
-$5.13 M(-11.2%)
-$20.34 M(+16.5%)
Sep 2020
-
-$5.78 M(+0.7%)
-$17.45 M(+17.4%)
Jun 2020
-
-$5.74 M(+55.9%)
-$14.87 M(+29.8%)
Mar 2020
-
-$3.68 M(+63.9%)
-$11.45 M(+1.0%)
Dec 2019
-$11.34 M
-$2.25 M(-29.7%)
-$11.35 M(-9.7%)
Sep 2019
-
-$3.20 M(+37.3%)
-$12.56 M(+1.3%)
Jun 2019
-
-$2.33 M(-34.9%)
-$12.40 M(-6.0%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$3.57 M(+3.3%)
-$13.19 M(+5.9%)
Dec 2018
-$12.45 M(-13.7%)
-$3.46 M(+13.9%)
-$12.45 M(+7.0%)
Sep 2018
-
-$3.04 M(-2.6%)
-$11.64 M(+0.3%)
Jun 2018
-
-$3.12 M(+10.0%)
-$11.60 M(-7.0%)
Mar 2018
-
-$2.83 M(+7.0%)
-$12.48 M(-13.5%)
Dec 2017
-$14.43 M(-21.4%)
-$2.65 M(-11.8%)
-$14.43 M(-11.7%)
Sep 2017
-
-$3.00 M(-24.7%)
-$16.34 M(-9.1%)
Jun 2017
-
-$3.99 M(-16.7%)
-$17.98 M(-4.6%)
Mar 2017
-
-$4.79 M(+5.0%)
-$18.85 M(+2.7%)
Dec 2016
-$18.36 M(+22.0%)
-$4.56 M(-1.8%)
-$18.36 M(-0.1%)
Sep 2016
-
-$4.64 M(-4.5%)
-$18.37 M(+1.0%)
Jun 2016
-
-$4.86 M(+13.1%)
-$18.20 M(+7.3%)
Mar 2016
-
-$4.30 M(-6.0%)
-$16.96 M(+12.6%)
Dec 2015
-$15.06 M(+201.9%)
-$4.57 M(+2.4%)
-$15.06 M(+28.5%)
Sep 2015
-
-$4.47 M(+23.2%)
-$11.71 M(+34.9%)
Jun 2015
-
-$3.62 M(+51.5%)
-$8.68 M(+36.8%)
Mar 2015
-
-$2.39 M(+94.6%)
-$6.35 M(+27.3%)
Dec 2014
-$4.99 M(-47.2%)
-$1.23 M(-14.4%)
-$4.99 M(+32.7%)
Sep 2014
-
-$1.44 M(+11.2%)
-$3.76 M(+61.8%)
Jun 2014
-
-$1.29 M(+25.3%)
-$2.32 M(+125.3%)
Mar 2014
-
-$1.03 M
-$1.03 M
Dec 2013
-$9.44 M
-
-

FAQ

  • What is OpGen annual EBITDA?
  • What is the all time high annual EBITDA for OpGen?
  • What is OpGen annual EBITDA year-on-year change?
  • What is OpGen quarterly EBITDA?
  • What is the all time high quarterly EBITDA for OpGen?
  • What is OpGen quarterly EBITDA year-on-year change?
  • What is OpGen TTM EBITDA?
  • What is the all time high TTM EBITDA for OpGen?
  • What is OpGen TTM EBITDA year-on-year change?

What is OpGen annual EBITDA?

The current annual EBITDA of OPGN is -$29.51 M

What is the all time high annual EBITDA for OpGen?

OpGen all-time high annual EBITDA is -$4.99 M

What is OpGen annual EBITDA year-on-year change?

Over the past year, OPGN annual EBITDA has changed by +$2.87 M (+8.87%)

What is OpGen quarterly EBITDA?

The current quarterly EBITDA of OPGN is $8.98 M

What is the all time high quarterly EBITDA for OpGen?

OpGen all-time high quarterly EBITDA is $8.98 M

What is OpGen quarterly EBITDA year-on-year change?

Over the past year, OPGN quarterly EBITDA has changed by $0.00 (0.00%)

What is OpGen TTM EBITDA?

The current TTM EBITDA of OPGN is -$8.88 M

What is the all time high TTM EBITDA for OpGen?

OpGen all-time high TTM EBITDA is -$1.03 M

What is OpGen TTM EBITDA year-on-year change?

Over the past year, OPGN TTM EBITDA has changed by $0.00 (0.00%)